ESC 365 - Will the technical improvements in atrial fibrillation ablation further improve the success of atrial fibrillation ablation.

ESC Premium Access

Will the technical improvements in atrial fibrillation ablation further improve the success of atrial fibrillation ablation.

Session: Is atrial fibrillation ablation a mature treatment to reduce morbi-mortality?

Topic: Outcomes and Complications

Speaker: Professor G. Hindricks (Berlin, DE)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Gerhard Hindricks

Charite University Hospital, Berlin (Germany)

84 presentations

30 followers

3 more presentations in this session

Effects of atrial fibrillation ablation in patients with stroke risk factors: the CABANA Trial.

Speaker: Doctor D. Packer (Salt Lake City, US)

Effects of atrial fibrillation ablation in patients with lV dysfunction: the CASTE-AF trial.

Speaker: Professor J. Brachmann (Coburg, DE)

Critical appraisal of the CABANA and CASTLE-AF trials.

Speaker: Professor I. Van Gelder (Groningen, NL)

Access the full session

Is atrial fibrillation ablation a mature treatment to reduce morbi-mortality?

Speakers: Professor G. Hindricks, Doctor D. Packer, Professor J. Brachmann, Professor I. Van Gelder

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources